[1] |
Urologic Chinese Oncology Group.
Expert consensus on early diagnosis and treatment of bladder cancer (2024 edition)
[J]. China Oncology, 2024, 34(6): 607-618.
|
[2] |
Professional Committee on Gastric Cancer of Shanghai Anticancer Association , Professional Committee on Gastrointestinal Cancer of China Association for Promotion of Health Science and Technology .
Chinese expert consensus on clinical practice of locally advanced gastric cancer invading adjacent organs (2024 edition)
[J]. China Oncology, 2024, 34(5): 517-526.
|
[3] |
MA Fenghua, JIANG Anqi, CHEN Yiqing, XU Congjian, KANG Yu.
Magnetic resonance imaging for distinguishing gastric-type endocervical adenocarcinoma from lobular endocervical glandular hyperplasia
[J]. China Oncology, 2024, 34(4): 380-388.
|
[4] |
Colorectal Cancer Special Committee of Shanghai Anti-Cancer Association .
Shanghai plan for early screening, diagnosis and treatment of colorectal cancer (2023 edition)
[J]. China Oncology, 2024, 34(1): 13-66.
|
[5] |
LI Tong, YANG Huijuan.
Progress in diagnosis and treatment of mucinous ovarian cancer
[J]. China Oncology, 2024, 34(1): 90-96.
|
[6] |
XU Hongtao, HUANG Xiaojuan, ZHENG Chongyang, ZHANG Zhiyuan.
Development and progress of fluorescence imaging technology in diagnosis and treatment of oral cancer
[J]. China Oncology, 2023, 33(9): 874-878.
|
[7] |
Society of Cancer of Multiple and Unknown Primary of China Anti-Cancer Association Yuguang .
China Anti-Cancer Association guideline for diagnosis and treatment of cancer of multiple and unknown primaries (2023 edition)
[J]. China Oncology, 2023, 33(4): 403-422.
|
[8] |
ZHENG Shengfeng, ZHU Yiping, YE Dingwei.
Advances in basic research, clinical diagnosis and treatment of bladder cancer in 2022
[J]. China Oncology, 2023, 33(3): 201-209.
|
[9] |
The Society of Breast Cancer China Anti-Cancer Association, Breast Oncology Group of the Oncology Branch of the Chinese Medical Association.
Guidelines for breast cancer diagnosis and treatment by China Anti-cancer Association (2024 edition)
[J]. China Oncology, 2023, 33(12): 1092-1187.
|
[10] |
GUO Qinhao, YU Min, WU Xiaohua.
Progress in diagnosis and treatment of gynecological tumors in 2022
[J]. China Oncology, 2023, 33(1): 14-24.
|
[11] |
GAO Heli, XU Jin, YU Xianjun.
Updates on the research and management of pancreatic neuroendocrine neoplasm in 2021
[J]. China Oncology, 2022, 32(9): 772-778.
|
[12] |
LIU Yanquan, HU Xiaomei, YIN Yue, LIN Lin, SHEN Jianzhen, CHEN Yuting, TANG Huanwen.
A retrospective study and clinical analysis of post-transplant lymphoproliferative disorder
[J]. China Oncology, 2022, 32(7): 650-656.
|
[13] |
The Society of Cancer Multidisciplinary Diagnosis and Treatment, China Anti-Cancer Association, The Society of Cancer Endocrinology, China Anti-Cancer Association.
Chinese experts consensus on quality control standards for tumor organoids diagnosis and treatment platform (2022 version)
[J]. China Oncology, 2022, 32(7): 657-668.
|
[14] |
Society of Neuroendocrine Neoplasm of China Anti-Cancer Association.
China Anti-Cancer Association guideline for diagnosis and treatment of neuroendocrine neoplasm (2022 edition)
[J]. China Oncology, 2022, 32(6): 545-579.
|
[15] |
The Society of Breast Cancer, China Anti-Cancer Association.
Screening and early diagnosis of breast cancer in China: a practice guideline
[J]. China Oncology, 2022, 32(4): 363-372.
|